Startups
Xavo is a software company with a sole focus on delivering exceptional value to Biopharma R&D through Software-as-a-Service. Xavo has reimagined how to address the strategic problem in the Biopharma R&D Sample Management realm which is to optimally fulfill changing demand for assays and materials based on available finite lab capacity and material inventory. With its SaaS product, Xavo R3, it helps Sample Management groups to consistently deliver the right material in the right format to the right recipient in the right quality to promise on time every time by providing the best combination means.
Overview
Location
Germany, Bavaria
Employees
51-200
Founded date
2000
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 27, 2023 | Accent Therapeutics upgrades to Xavo R3 for their small molecule Compound Management needs | Xavo, a leading provider of Software-as-a-Service for Biopharma R&D announces that Accent Therapeutics has gone live with the latest version of Xavo R3. BOSTON, MA, USA, February 27, 2023 /EINPresswire.com/ -- Xavo, a leading provider o... |
Reviews 0
FAQ about Xavo
When was Xavo founded?
Xavo was founded in 2000.
What has the press written about Xavo?
Parsers VC has collected 2 articles mentioning Xavo, among them “Accent Therapeutics upgrades to Xavo R3 for their small molecule Compound Management needs” (Feb 27, 2023).
Is Xavo still active?
Yes, Xavo is active; its latest activity on Parsers VC dates from Feb 27, 2023.